These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 10446959
1. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Luo J, Lubaroff DM, Hendrix MJ. Cancer Res; 1999 Aug 01; 59(15):3552-6. PubMed ID: 10446959 [Abstract] [Full Text] [Related]
2. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB. Cancer Res; 1995 Nov 01; 55(21):4813-7. PubMed ID: 7585512 [Abstract] [Full Text] [Related]
3. Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells. Nwankwo JO. Anticancer Res; 2002 Nov 01; 22(6C):4129-35. PubMed ID: 12553043 [Abstract] [Full Text] [Related]
4. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA. Cancer Res; 1992 May 15; 52(10):2916-22. PubMed ID: 1581909 [Abstract] [Full Text] [Related]
5. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S. Cancer Res; 2003 May 01; 63(9):2278-83. PubMed ID: 12727850 [Abstract] [Full Text] [Related]
6. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, Hoang BH. Cancer Res; 2005 Nov 01; 65(21):9762-70. PubMed ID: 16266997 [Abstract] [Full Text] [Related]
7. Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors. Moersig W, Horn S, Hilker M, Mayer E, Oelert H. Thorac Cardiovasc Surg; 2002 Feb 01; 50(1):45-8. PubMed ID: 11847604 [Abstract] [Full Text] [Related]
8. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. Davies G, Jiang WG, Mason MD. J Urol; 2000 Mar 01; 163(3):985-92. PubMed ID: 10688036 [Abstract] [Full Text] [Related]
9. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Davies G, Jiang WG, Mason MD. Clin Cancer Res; 2001 Oct 01; 7(10):3289-97. PubMed ID: 11595727 [Abstract] [Full Text] [Related]
10. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Che G, Chen J, Liu L, Wang Y, Li L, Qin Y, Zhou Q. Neoplasma; 2006 Oct 01; 53(6):530-7. PubMed ID: 17167724 [Abstract] [Full Text] [Related]
11. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Llorens A, Rodrigo I, López-Barcons L, Gonzalez-Garrigues M, Lozano E, Vinyals A, Quintanilla M, Cano A, Fabra A. Lab Invest; 1998 Sep 01; 78(9):1131-42. PubMed ID: 9759657 [Abstract] [Full Text] [Related]
12. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. Cancer Res; 2005 Mar 01; 65(5):1783-91. PubMed ID: 15753375 [Abstract] [Full Text] [Related]
13. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Wilding J, Vousden KH, Soutter WP, McCrea PD, Del Buono R, Pignatelli M. Cancer Res; 1996 Nov 15; 56(22):5285-92. PubMed ID: 8912870 [Abstract] [Full Text] [Related]
14. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH. Int J Oncol; 2002 Jul 15; 21(1):135-44. PubMed ID: 12063560 [Abstract] [Full Text] [Related]
15. Cadherin switching in human prostate cancer progression. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA. Cancer Res; 2000 Jul 01; 60(13):3650-4. PubMed ID: 10910081 [Abstract] [Full Text] [Related]
16. E-cadherin expression: a counterbalance for cancer cell invasion. Mareel M, Vleminckx K, Vermeulen S, Bracke M, Van Roy F. Bull Cancer; 1992 Jul 01; 79(4):347-55. PubMed ID: 1421692 [Abstract] [Full Text] [Related]
17. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP. Clin Cancer Res; 2001 Sep 01; 7(9):2840-53. PubMed ID: 11555602 [Abstract] [Full Text] [Related]
18. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR. Eur Surg Res; 2007 Sep 01; 39(4):208-15. PubMed ID: 17396032 [Abstract] [Full Text] [Related]
19. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Kamidono S. Cancer Res; 1996 May 15; 56(10):2440-5. PubMed ID: 8625325 [Abstract] [Full Text] [Related]
20. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM. Prostate; 2007 Jul 01; 67(10):1081-90. PubMed ID: 17476687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]